Neuralink, Elon Musk’s brain implant company came up with an announcement to launch a clinical study on their brain implant chips in Great Britain to examine how it will work with patients who were suffering with paralysis.They said the company research will be done in Great Britain in collaboration with University College London Hospitals trust and Newcastle Hospitals.
The company said that people who are upkeep with paralysis because of spinal cord injury and a nervous system disease called Amyotrophic Lateral Sclerosis (ALS) are allowed to take part in study.This chip will make it possible for the patient to control their digital tools with their thoughts.
What’s the Mission
Neuralink is a brain implant company which helps the people who are suffering with paralysis. The company does surgeries and puts the chip inside people’s brain to allow their brain to communicate with the computer or they can control a digital tool with their thoughts. According to the company there are five people who successfully did this implant and used their chips.
Company legacy
The company was founded by Elon Musk in 2016, according to the report, and citing PitchBook, the company raised about $1.3 billion from investors which is roughly Rs 11,360 crore and is valued at roughly $9 billion which is roughly Rs 78,714 crore.
They started bring implant trail on human in 2014 after work out with safety concerns marked out by US food and drug administration, last month with its latest funding the company raise $650 million which is roughly Rs 5,676 crore.
Input from Ahsan Khan.